We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Sunday, November 24, 2024
Extensive internal and external feedback is leading the Food and Drug Administration to further refine a reorganizational plan to include clear responsibilities for the leader of the Human Foods Program and significant changes for its Office of Regulatory Affairs.
A key dairy-state lawmaker and Senate Agriculture Committee member hopes the 2023 farm bill will help expand rural broadband service, and he also believes that it's also critical for Congress to address ag labor needs.
We’re still months away from seeing a new farm bill on the House and Senate farm bill, but ag groups could get a look as soon as next month at the challenges they may face in protecting crop insurance and other programs.
That didn’t last long. Just two weeks after Congress passed the debt ceiling agreement, the fiscal 2024 spending process is getting off to a rocky start.
There’s one week left to submit comments to the House Agriculture Committee on what should – or shouldn’t – be in the next farm bill. So far, the committee has received nearly 1,400 submissions, according to staff.
The Food and Drug Administration has taken baby steps in helping advance approvals of gene-edited animals for food production; however, the insistence by FDA that changing an animal’s DNA is a “drug” and out of USDA’s purview could keep innovation decades away from producer adoption.
House Appropriations Committee Chairwoman Kay Granger on Tuesday postponed scheduled action on the fiscal 2024 Agriculture spending bill and three other measures, citing the ongoing negotiations with the White House over the debt ceiling limit.
Republicans on the House Ag Appropriations Subcommittee on Thursday advanced a fiscal 2024 spending bill for USDA and FDA over Democratic accusations that it was a “sham proposal” that relied on funding rescissions that were unlikely to materialize in time.
